N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide

C19H24F5N5O — CID 166499899

IUPACN-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide
SMILESC[C@H](NC(=O)CCC(F)(F)F)c1cnn2cc([C@@H](N)C3CCC(F)(F)CC3)nc2c1
InChIInChI=1S/C19H24F5N5O/c1-11(27-16(30)4-7-19(22,23)24)13-8-15-28-14(10-29(15)26-9-13)17(25)12-2-5-18(20,21)6-3-12/h8-12,17H,2-7,25H2,1H3,(H,27,30)/t11-,17-/m0/s1
InChIKeyMIRBFMSXFMHDRN-GTNSWQLSSA-N
MW433.43 g/mol
LogP4.07
Rot. Bonds6

About N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide

N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide (PubChem CID 166499899) has the molecular formula C19H24F5N5O and a molecular weight of 433.43 g/mol. Its IUPAC name is N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide.

Molecular Properties

Compound NameN-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide
PubChem CID166499899
Molecular FormulaC19H24F5N5O
Molecular Weight433.43 g/mol
Exact Mass433.19
IUPAC NameN-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide
SMILESC[C@H](NC(=O)CCC(F)(F)F)c1cnn2cc([C@@H](N)C3CCC(F)(F)CC3)nc2c1
InChIInChI=1S/C19H24F5N5O/c1-11(27-16(30)4-7-19(22,23)24)13-8-15-28-14(10-29(15)26-9-13)17(25)12-2-5-18(20,21)6-3-12/h8-12,17H,2-7,25H2,1H3,(H,27,30)/t11-,17-/m0/s1
InChIKeyMIRBFMSXFMHDRN-GTNSWQLSSA-N
XLogP4.07
TPSA85.31 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500433.43
LogP ≤ 54.07
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide?
The IUPAC name of N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide (CID 166499899) is N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide.
What is the SMILES notation for N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide?
The canonical SMILES for N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide is C[C@H](NC(=O)CCC(F)(F)F)c1cnn2cc([C@@H](N)C3CCC(F)(F)CC3)nc2c1.
What is the InChIKey of N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide?
The InChIKey is MIRBFMSXFMHDRN-GTNSWQLSSA-N. The full InChI is InChI=1S/C19H24F5N5O/c1-11(27-16(30)4-7-19(22,23)24)13-8-15-28-14(10-29(15)26-9-13)17(25)12-2-5-18(20,21)6-3-12/h8-12,17H,2-7,25H2,1H3,(H,27,30)/t11-,17-/m0/s1.
What are the key properties of N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide?
N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide has a molecular weight of 433.43 g/mol, XLogP of 4.07, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]ethyl]-4,4,4-trifluorobutanamide is sourced from PubChem (CID 166499899), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).